Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system 


Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood


11 Apr 2023

Epimune to present ongoing research in Non-Hodgkin Lymphoma (NHL) at AACR 2023.

For a Spanish version of this video please click here!